Glossary

The ongoing review of participant adherence to the trial protocol.

A platform for collecting and analyzing adverse event data from clinical trials.

Data collected outside clinical trials, used to support the safety and effectiveness of treatments.

Comparing the effectiveness of two or more treatments in a clinical trial.

A drug provided to participants to alleviate symptoms if the primary treatment fails.

A formal change to the trial protocol after it has been approved.

The rate at which participants drop out of a clinical trial.

The ability of a treatment to produce the desired effect in real-world clinical practice.

The proportion of participants who complete the trial as planned.

A study design where two or more groups receive different treatments simultaneously.

The criteria that determine who can participate in a clinical trial.

Independent analysis of medical images, such as X-rays or MRIs, by a central reviewer.

A monitoring approach focusing on high-risk areas of the trial to improve efficiency.

Categorizing adverse events based on their severity and impact.